|
PTGR2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.328381848964E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.01590003076524E-09 |
| Normal-vs-Stage2 |
1.85650000039672E-07 |
| Normal-vs-Stage3 |
3.33066907387547E-16 |
| Normal-vs-Stage4 |
1.62658775337832E-12 |
| Stage1-vs-Stage2 |
5.446200E-01 |
| Stage1-vs-Stage3 |
3.27799998256495E-09 |
| Stage1-vs-Stage4 |
1.87709999999175E-06 |
| Stage2-vs-Stage3 |
1.075560E-02 |
| Stage2-vs-Stage4 |
2.100100E-02 |
| Stage3-vs-Stage4 |
8.390800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.34314781519151E-12 |
| Normal-vs-AfricanAmerican |
4.2623005125364E-10 |
| Normal-vs-Asian |
4.364700E-03 |
| Caucasian-vs-AfricanAmerican |
9.023800E-01 |
| Caucasian-vs-Asian |
8.637000E-01 |
| AfricanAmerican-vs-Asian |
8.205400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.9302337506133E-12 |
| Normal-vs-Female |
8.8418050658845E-11 |
| Male-vs-Female |
6.223800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.70605999999518E-05 |
| Normal-vs-Age(41-60Yrs) |
2.31870078692964E-11 |
| Normal-vs-Age(61-80Yrs) |
1.85040871514275E-12 |
| Normal-vs-Age(81-100Yrs) |
3.81360000000219E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.695000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.481600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.993400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.963700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.758600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.710800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.002430E-01 |
| Normal-vs-Grade 2 |
4.02690003564743E-09 |
| Normal-vs-Grade 3 |
3.35287353436797E-14 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
9.934300E-02 |
| Grade 1-vs-Grade 3 |
2.977000E-04 |
| Grade 1-vs-Grade 4 |
8.14479994559747E-09 |
| Grade 2-vs-Grade 3 |
3.75600000002141E-06 |
| Grade 2-vs-Grade 4 |
1.37667655053519E-14 |
| Grade 3-vs-Grade 4 |
1.52897999999846E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.33920000223409E-08 |
| Normal-vs-ccB subtype |
1.62481139653892E-12 |
| ccA subtype-vs-ccB subtype |
4.99544849930089E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.4426463336199E-12 |
| Normal-vs-N1 |
2.30926389122033E-14 |
| N0-vs-N1 |
1.975050E-04 |
|
|
